Sankara Diagnostics Private Limited, a struck off private limited company, was established on 18 July 2012 in Hyderabad, Telangana, India. Engaging in diagnostic centers & pathology labs within the healthcare sector, it holds CIN: U85195TG2012PTC082046. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹7.55 Cr.
It upholds a compliant status. Its leadership includes Dahagam Uma (Director), Tulasi Das Devalla (Director). Past directors included Rajam Laxmi Chilappagari, Ravi Kiran Rayapaty, Suresh Kumar Reddy Medipalli. It holds no open charges and ₹5.25 Cr settled loans. Its latest AGM occurred on 13 October 2020, with the balance sheet filed on 31 March 2020. It is based at Plot No.1267/A, 8-2-293/82/A/1267/A Road No.63/A, Jubilee Hills,, Hyderabad, Telangana, 500033.
U85195TG2012PTC082046
082046
18 July 2012
₹12.00 Cr
₹7.55 Cr
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Sankara Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dahagam Uma | Director | 16 Mar 2019 | Current |
| Tulasi Das Devalla | Director | 16 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Mar 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2015 | Past |
| Pramod Abcsdd | Director | 21 Mar 2019 | Past |
| Pramod Abcsdd | Director | 24 Apr 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sankara Diagnostics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 100.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 96.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Sankara Diagnostics had a promoter holding of 59.89% and a public holding of 40.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹52,501,602.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2013 | Ge Capital Services India | ₹5.35 M | Satisfied |
| 08 Aug 2013 | Ge Capital Services India | ₹7.91 M | Satisfied |
| 19 Jun 2013 | Ge Capital Services India | ₹1.30 Cr | Satisfied |
| 18 Jun 2013 | Ge Capital Services India | ₹2.63 Cr | Satisfied |
Explore comprehensive loan charge details -
Sankara Diagnostics has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sankara Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sankara Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sankara Diagnostics Private Limited last Annual general meeting of members was held on 13 Oct 2020 as per latest MCA records. was documented.
Sankara Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was recorded as a recent event.
Dahagam Uma was appointed as a Director was appointed as a Director on 16 Mar 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Progress on Tulasi Das Devalla was appointed as a Director was appointed as a Director on 16 Mar 2019 & has been associated with this company since 6 years 9 months . was documented.
The activity A charge registered on 03 Dec 2013 via Charge ID 10463325 with Ge Capital Services India was fully satisfied on 03 Jun 2016. was completed.
The activity A charge registered on 08 Aug 2013 via Charge ID 10443373 with Ge Capital Services India was fully satisfied on 03 Jun 2016. was completed.
The CIN of Sankara Diagnostics Private Limited is U85195TG2012PTC082046.
Sankara Diagnostics Private Limited is headquartered at Plot No.1267/A, 8-2-293/82/A/1267/A Road No.63/A, Jubilee Hills,, Hyderabad, Telangana, 500033.
Sankara Diagnostics Private Limited was incorporated on 18 July 2012.
The current directors of Sankara Diagnostics Private Limited are
The primary industry of Sankara Diagnostics Private Limited is Healthcare.
Sankara Diagnostics Private Limited is unlisted.
The authorized capital of Sankara Diagnostics Private Limited is ₹12.00 Cr, and the paid-up capital is ₹7.55 Cr.
The compliance status of Sankara Diagnostics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX